title: Sleep quality and architecture in quetiapine, risperidone, or never-treated schizophrenia patients.
authors.forename: Matcheri S
authors.initials: MS
authors.lastname: Keshavan
authors.forename: Konasale M
authors.initials: KM
authors.lastname: Prasad
authors.forename: Debra M
authors.initials: DM
authors.lastname: Montrose
authors.forename: Jean M
authors.initials: JM
authors.lastname: Miewald
authors.forename: David J
authors.initials: DJ
authors.lastname: Kupfer
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use; D039721:Diagnostic and Statistical Manual of Mental Disorders; D003987:Dibenzothiazepines / Q000494:pharmacology / Q000627:therapeutic use*; D065127:Dopamine D2 Receptor Antagonists; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography / Q000379:methods; D006801:Humans; D008297:Male; D008875:Middle Aged; D017286:Polysomnography / Q000379:methods; D000069348:Quetiapine Fumarate; D015203:Reproducibility of Results; D018967:Risperidone / Q000627:therapeutic use*; D018401:Sample Size; D012559:Schizophrenia / Q000188:drug therapy*; D012890:Sleep / Q000187:drug effects* / Q000502:physiology; D012895:Sleep, REM / Q000187:drug effects / Q000502:physiology
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D065127:Dopamine D2 Receptor Antagonists; D000069348:Quetiapine Fumarate; D018967:Risperidone